65757-402 : Aristada 662 mg/2.4ml Intramuscular Injection, Suspension, Extended Release


NDC65757-402
Labeler: Alkermes, Inc.
Product Type: Human Prescription Drug
Drug Name:  Aristada
Dosage Form: Intramuscular Injection, Suspension, Extended Release
Application #: NDA207533
Rev. Date: 


NDC Package Codes:

  • 65757-402-03: 1 SYRINGE IN 1 CARTON (65757‑402‑03) > 2.4 ML IN 1 SYRINGE (65757‑402‑01)

Active Ingredients:

  • Aripiprazole Lauroxil

Dosage Strength:

  • 662 mg/2.4mL

Related Products:

Based on records with the same trade name.
  • 65757-401 Aristada 441 mg/1.6ml Intramuscular Injection, Suspension, Extended Release by Alkermes, Inc.
  • 65757-403 Aristada 882 mg/3.2ml Intramuscular Injection, Suspension, Extended Release by Alkermes, Inc.
  • 65757-404 Aristada 1064 mg/3.9ml Intramuscular Injection, Suspension, Extended Release by Alkermes, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 65757-402 QR Code

< Prev: 65757-401Next: 65757-403 >

Related Discussions:

Aripiprazole antipsychotic medication
## I would like to more information regarding this medication. My 4 year old son was just put on this medication for bi-... 3 replies
Aripiprazole and Fluoxetine
I'm on 10mg of aripiprazole and 40mg fluoxetine. I was feeling suicidal before. Is this medication going to help? I&... 2 replies




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.